PostYou are now at: Home » Products » Chemicals » Other Chemicals »

Letrozole

Click image to view original image
Price: Negotiable
Min.Order:
Supply
Delivery: Shipment within 3 days since the date of payment
Address: China
Valid until: Never Expire
Updated on: 2015-03-16 17:11
Hits: 486161
Enquiry
Company Detail
 
 
Details
 Letrozole    vicky at chembj dot com

Supplied by Wuhan Hezhong Bio-Chemical Manufacture Co., Ltd.
Contact: vicky Huang
Skype: vickyhj90
Tel:86-27-50755980
Cell:86 18872220733 

1.      Quick Details:

Letrozole

Alias: Femara, Letrozole, TROZET

CAS Registry Number:112809-51-5

Purity: 98%

MF: C17H11N5

MW: 285.3

Character: White crystalline powder.

Manufacturer :Hezhong

Delivery time :within 18 hours upon receipt of payment

Delivery: EMS, DHL, TNT, FedEx, UPS

Other drugs in same class:Anastrozole,Letrozole,Tamoxifen citrate,Exemestane

Usage: Letrozole is a powerful Aromatase Inhibitor that was developed to fight breast cancer. For athletes and bodybuilders, it is a drug used to combat the estrogenic side effects of anabolic steroids water-retention, acne and gynocomastia. It will also raise testosterone levels because of the lowered estrogen in the body. Side effects from Letrozole include a lowered sex drive and continuous use can lead to lowered lipid function and an impaired immune system.

2.       Product Description:

Product name

Letrozole

Other name

Femara, Letrozole, TROZET 

CAS register number

112809-51-5

Molecular formula

C17H11N5

Molecular weight

285.3

Molecular structure

 

Assay

98%

Appearance

White crystalline powder

Package

1kg/aluminium foil bag or as required

Usage

can be used as pharmaceutical material

Minimum order quantity

10g

Shipping

By express courier

Shipping leading time

Within 18 hours after receiving the payment

Payment options

Western unio, MoneyGram, T/T

Price

Negotiated

3.  Applications:

Letrozole has been used for ovarian stimulation by fertility doctors since 2001 because it has fewer side-effects than clomiphene (Clomid) and less chance of multiple gestation. A Canadian study presented at the American Society of Reproductive Medicine 2005 Conference suggested that letrozole may increase the risk of birth defects.[citation needed] A more detailed ovulation induction follow-up study found that letrozole, compared with a control group of clomiphene, had significantly lower congenital malformations and chromosomal abnormalities at an overall rate of 2.4% (1.2% major malformations) compared with clomiphene 4.8% (3.0% major malformations). Despite this, India banned the usage of letrozole in 2011, citing potential risks to infants.In 2012, an Indian parliamentary committee said that the drug controller office colluded with letrozole's makers to approve the drug for infertility in India and also stated that letrozole's use for infertility was illegal worldwide; however, such off-label uses are legal in many countries such as the US and UK.

Total: 0 [Show All]  Related Reviews
 
More »Our Others Products

[ ProductsSearch ]  [ Add To Favourite ]  [ Tell Friends ]  [ Print Content ]  [ Violation Report ]  [ Close Window ]